Switching Outpatients With Schizophrenia and Related Disorders on Long-Acting Injectable Antipsychotics to Olanzapine: An Open-Label Naturalistic Pilot Study
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Switching Outpatients With Schizophrenia and Related Disorders on Long-Acting Injectable Antipsychotics to Olanzapine: An Open-Label Naturalistic Pilot Study